<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37872557</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>27</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1750-1326</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Oct</Month><Day>23</Day></PubDate></JournalIssue><Title>Molecular neurodegeneration</Title><ISOAbbreviation>Mol Neurodegener</ISOAbbreviation></Journal><ArticleTitle>Genome-wide analyses identify NEAT1 as genetic modifier of age at onset of amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>77</StartPage><MedlinePgn>77</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">77</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13024-023-00669-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Patients with amyotrophic lateral sclerosis (ALS) demonstrate great heterogeneity in the age at onset (AAO), which is closely related to the course of disease. However, most genetic studies focused on the risk of ALS, while the genetic background underlying AAO of ALS is still unknown.</AbstractText><AbstractText Label="METHODS">To identify genetic determinants influencing AAO of ALS, we performed genome-wide association analysis using a Cox proportional hazards model in 2,841 patients with ALS (N<sub>discovery</sub> = 2,272, N<sub>replication</sub> = 569) in the Chinese population. We further conducted colocalization analysis using public cis-eQTL dataset, and Mendelian randomization analysis to identify risk factors for AAO of ALS. Finally, functional experiments including dual-luciferase reporter assay and RT-qPCR were performed to explore the regulatory effect of the target variant.</AbstractText><AbstractText Label="RESULTS">The total heritability of AAO of ALS was ~&#x2009;0.24. One novel locus rs10128627 (FRMD8) was significantly associated with earlier AAO by ~&#x2009;3.15 years (P&#x2009;=&#x2009;1.54E-08, beta&#x2009;=&#x2009;0.31, SE&#x2009;=&#x2009;0.05). This locus was cis-eQTL of NEAT1 in multiple brain tissues and blood. Colocalization analysis detected association signals at this locus between AAO of ALS and expression of NEAT1. Furthermore, functional exploration supported the variant rs10128627 was associated with upregulated expression of NEAT1 in cell models and patients with ALS. Causal inference suggested higher total cholesterol, low-density lipoprotein, and eosinophil were nominally associated with earlier AAO of ALS, while monocyte might delay the AAO.</AbstractText><AbstractText Label="CONCLUSIONS">Collective evidence from genetic, bioinformatic, and functional results suggested NEAT1 as a key player in the disease progression of ALS. These findings improve the current understanding of the genetic role in AAO of ALS, and provide a novel target for further research on the pathogenesis and therapeutic options to delay the disease onset.</AbstractText><CopyrightInformation>&#xa9; 2023. Editorial Group and BioMed Central Ltd., part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chunyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Qianqian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Yanbing</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Junyu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ou</LastName><ForeName>Ruwei</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lingyu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Qirui</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Kuncheng</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xueping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>TianMi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Bi</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shang</LastName><ForeName>Huifang</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0003-0947-1151</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Laboratory of Neurodegenerative Disorders, West China Hospital, National Clinical Research Center for Geriatric, Sichuan University, Chengdu, China. hfshang2002@126.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Mol Neurodegener</MedlineTA><NlmUniqueID>101266600</NlmUniqueID><ISSNLinking>1750-1326</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="N">Genome-Wide Association Study</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017668" MajorTopicYN="N">Age of Onset</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Age at onset</Keyword><Keyword MajorTopicYN="N">Amyotrophic Lateral Sclerosis</Keyword><Keyword MajorTopicYN="N">GWAS</Keyword><Keyword MajorTopicYN="N">Genetic modifiers</Keyword><Keyword MajorTopicYN="N">NEAT1</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>24</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>23</Hour><Minute>50</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37872557</ArticleId><ArticleId IdType="pmc">PMC10594666</ArticleId><ArticleId IdType="doi">10.1186/s13024-023-00669-6</ArticleId><ArticleId IdType="pii">10.1186/s13024-023-00669-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>van Es MA, Hardiman O, Chio A, Al-Chalabi A, Pasterkamp RJ, Veldink JH, van den Berg LH. Amyotrophic Lateral Sclerosis. Lancet (London England) 2017;390:2084&#x2013;98. doi: 10.1016/S0140-6736(17)31287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(17)31287-4</ArticleId><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu MS, Cui LY, Fan DS. Age at onset of Amyotrophic Lateral Sclerosis in China. Acta Neurol Scand. 2014;129:163&#x2013;7. doi: 10.1111/ane.12157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12157</ArticleId><ArticleId IdType="pubmed">23819875</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A, Moglia C, Canosa A, Manera U, D&#x2019;Ovidio F, Vasta R, Grassano M, Brunetti M, Barberis M, Corrado L, et al. ALS phenotype is influenced by age, sex, and genetics: a population-based study. Neurology. 2020;94:E802&#x2013;10. doi: 10.1212/WNL.0000000000008869.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000008869</ArticleId><ArticleId IdType="pubmed">31907290</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraro PM, Cabona C, Meo G, Rolla-Bigliani C, Castellan L, Pardini M, Inglese M, Caponnetto C, Roccatagliata L. Age at symptom onset influences cortical thinning distribution and survival in amyotrophic lateral sclerosis. Neuroradiology 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33660067</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, Tanaka F, Tamakoshi A, Nakano I, Aoki M, Tsuji S, Yuasa T, Takano H, et al. Age at onset influences on wide-ranged clinical features of sporadic Amyotrophic Lateral Sclerosis. J Neurol Sci. 2009;276:163&#x2013;9. doi: 10.1016/j.jns.2008.09.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.09.024</ArticleId><ArticleId IdType="pubmed">18962725</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E, Bianchi E, Vanacore N, Montalto C, Ricca G, Della Cuna FSR, Fumagalli F, Castellani M, Poli F, Romeo F, et al. Increased risk and early onset of ALS in professional players from Italian Soccer teams. Amyotroph Lateral Scher Frontotemp Degenerat. 2020;21:403&#x2013;9. doi: 10.1080/21678421.2020.1752250.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2020.1752250</ArticleId><ArticleId IdType="pubmed">32321311</ArticleId></ArticleIdList></Reference><Reference><Citation>Naruse H, Ishiura H, Mitsui J, Takahashi Y, Matsukawa T, Tanaka M, Doi K, Yoshimura J, Morishita S, Goto J, et al. Burden of rare variants in causative genes for Amyotrophic Lateral Sclerosis (ALS) accelerates age at onset of ALS. J Neurol Neurosurg Psychiatry. 2019;90:537&#x2013;42. doi: 10.1136/jnnp-2018-318568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318568</ArticleId><ArticleId IdType="pubmed">30355605</ArticleId></ArticleIdList></Reference><Reference><Citation>Langefeld CD, Consortium A. Age of onset of Amyotrophic Lateral Sclerosis is modulated by a locus on 1p34.1. Neurobiol Aging 2013, 34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3839234</ArticleId><ArticleId IdType="pubmed">22959728</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of Amyotrophic Lateral Sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disorders: Official Publication World Federation Neurol Res Group Motor Neuron Dis. 2000;1:293&#x2013;9. doi: 10.1080/146608200300079536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/146608200300079536</ArticleId><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Hou Y, Ou R, Gu X, Chen Y, Zhang L, Liu K, Lin J, Cao B, Wei Q, et al. Genetic determinants of Survival in Parkinson&#x2019;s Disease in the Asian Population. Mov Disorders: Official J Mov Disorder Soc. 2022;37:1624&#x2013;33. doi: 10.1002/mds.29069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.29069</ArticleId><ArticleId IdType="pubmed">35616254</ArticleId></ArticleIdList></Reference><Reference><Citation>Das S, Forer L, Sch&#xf6;nherr S, Sidore C, Locke AE, Kwong A, Vrieze SI, Chew EY, Levy S, McGue M, et al. Next-generation genotype imputation service and methods. Nat Genet. 2016;48:1284&#x2013;7. doi: 10.1038/ng.3656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3656</ArticleId><ArticleId IdType="pmc">PMC5157836</ArticleId><ArticleId IdType="pubmed">27571263</ArticleId></ArticleIdList></Reference><Reference><Citation>de Leeuw CA, Mooij JM, Heskes T, Posthuma D. MAGMA: generalized gene-set analysis of GWAS data. PLoS Comput Biol. 2015;11:e1004219. doi: 10.1371/journal.pcbi.1004219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1004219</ArticleId><ArticleId IdType="pmc">PMC4401657</ArticleId><ArticleId IdType="pubmed">25885710</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SW, O&#x2019;Reilly PF. PRSice-2: polygenic risk score software for biobank-scale data. GigaScience 2019, 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6629542</ArticleId><ArticleId IdType="pubmed">31307061</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, van der Spek RAA, Bakker MK, van Vugt JJFA, Hop PJ, Zwamborn RAJ, de Klein N, Westra H-J, Bakker OB, Deelen P, et al. Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53:1636&#x2013;48. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Benyamin B, He J, Zhao Q, Gratten J, Garton F, Leo PJ, Liu Z, Mangelsdorf M, Al-Chalabi A, Anderson L, et al. Cross-ethnic meta-analysis identifies association of the GPX3-TNIP1 locus with Amyotrophic Lateral Sclerosis. Nat Commun. 2017;8:611. doi: 10.1038/s41467-017-00471-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00471-1</ArticleId><ArticleId IdType="pmc">PMC5606989</ArticleId><ArticleId IdType="pubmed">28931804</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura R, Misawa K, Tohnai G, Nakatochi M, Furuhashi S, Atsuta N, Hayashi N, Yokoi D, Watanabe H, Watanabe H, et al. A multi-ethnic meta-analysis identifies novel genes, including ACSL5, associated with Amyotrophic Lateral Sclerosis. Commun Biology. 2020;3:526. doi: 10.1038/s42003-020-01251-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-020-01251-2</ArticleId><ArticleId IdType="pmc">PMC7511394</ArticleId><ArticleId IdType="pubmed">32968195</ArticleId></ArticleIdList></Reference><Reference><Citation>Gamazon ER, Segr&#xe8; AV, van de Bunt M, Wen X, Xi HS, Hormozdiari F, Ongen H, Konkashbaev A, Derks EM, Aguet F, et al. Using an atlas of gene regulation across 44 human tissues to inform complex disease- and trait-associated variation. Nat Genet. 2018;50:956&#x2013;67. doi: 10.1038/s41588-018-0154-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0154-4</ArticleId><ArticleId IdType="pmc">PMC6248311</ArticleId><ArticleId IdType="pubmed">29955180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Huang D, Wang J, Zhao K, Zhou Y, Guo Z, Zhai S, Xu H, Cui H, Yao H, et al. QTLbase: an integrative resource for quantitative trait loci across multiple human molecular phenotypes. Nucleic Acids Res. 2019;48:D983&#x2013;91. doi: 10.1093/nar/gkz888.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz888</ArticleId><ArticleId IdType="pmc">PMC6943073</ArticleId><ArticleId IdType="pubmed">31598699</ArticleId></ArticleIdList></Reference><Reference><Citation>Fishilevich S, Nudel R, Rappaport N, Hadar R, Plaschkes I, Iny Stein T, Rosen N, Kohn A, Twik M, Safran M et al. GeneHancer: genome-wide integration of enhancers and target genes in GeneCards. Database: The Journal of Biological Databases and Curation 2017, 2017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467550</ArticleId><ArticleId IdType="pubmed">28605766</ArticleId></ArticleIdList></Reference><Reference><Citation>Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, Plagnol V. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383. doi: 10.1371/journal.pgen.1004383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1004383</ArticleId><ArticleId IdType="pmc">PMC4022491</ArticleId><ArticleId IdType="pubmed">24830394</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardlie KG, DeLuca DS, Segre AV, Sullivan TJ, Young TR, Gelfand ET, Trowbridge CA, Maller JB, Tukiainen T, Lek M, et al. The genotype-tissue expression (GTEx) pilot analysis: Multitissue gene regulation in humans. Sci (New York NY) 2015;348:648&#x2013;60. doi: 10.1126/science.1262110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1262110</ArticleId><ArticleId IdType="pmc">PMC4547484</ArticleId><ArticleId IdType="pubmed">25954001</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Hou Y, Ou R, Gu X, Chen Y, Zhang L, Liu K, Lin J, Cao B, Wei Q, et al. Genetic determinants of Survival in Parkinson&#x2019;s Disease in the Asian Population. Mov Disord. 2022;37:1624&#x2013;33. doi: 10.1002/mds.29069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.29069</ArticleId><ArticleId IdType="pubmed">35616254</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Liu J, Lin J, Shang H. COVID-19 and risk of neurodegenerative disorders: a mendelian randomization study. Translational Psychiatry. 2022;12:283. doi: 10.1038/s41398-022-02052-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-022-02052-3</ArticleId><ArticleId IdType="pmc">PMC9281279</ArticleId><ArticleId IdType="pubmed">35835752</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Ou R, Shang H. Rheumatoid arthritis decreases risk for Parkinson&#x2019;s Disease: a mendelian randomization study. Npj Parkinson&#x2019;s Disease. 2021;7:17. doi: 10.1038/s41531-021-00166-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41531-021-00166-x</ArticleId><ArticleId IdType="pmc">PMC7925660</ArticleId><ArticleId IdType="pubmed">33654087</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, Laurin C, Burgess S, Bowden J, Langdon R et al. The MR-Base platform supports systematic causal inference across the human phenome. eLife 2018, 7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976434</ArticleId><ArticleId IdType="pubmed">29846171</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J, Lee SH, Goddard ME, Visscher PM. GCTA: a tool for genome-wide complex trait analysis. Am J Hum Genet. 2011;88:76&#x2013;82. doi: 10.1016/j.ajhg.2010.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2010.11.011</ArticleId><ArticleId IdType="pmc">PMC3014363</ArticleId><ArticleId IdType="pubmed">21167468</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, McLaughlin RL, Hardiman O. Lifetime risk and heritability of Amyotrophic Lateral Sclerosis. JAMA Neurol. 2019;76:1367&#x2013;74. doi: 10.1001/jamaneurol.2019.2044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.2044</ArticleId><ArticleId IdType="pmc">PMC6646974</ArticleId><ArticleId IdType="pubmed">31329211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan M, Heverin M, Pender N, McLaughlin R, Hardiman O. Heritability of ALS: a Population-based study over 24 years. (S54.001) Neurology. 2019;92:54001.</Citation></Reference><Reference><Citation>Li C, Ou R, Chen Y, Gu X, Wei Q, Cao B, Zhang L, Hou Y, Liu K, Chen X et al. Genetic Modifiers of Age at Onset for Parkinson&#x2019;s Disease in Asians: A Genome-Wide Association Study. Mov Disorders: Official J Mov Disorder Soc 2021.</Citation><ArticleIdList><ArticleId IdType="pubmed">33884653</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruchaga C, Del-Aguila JL, Saef B, Black K, Fernandez MV, Budde J, Ibanez L, Deming Y, Kapoor M, Tosto G, et al. Polygenic risk score of sporadic late-onset Alzheimer&#x2019;s Disease reveals a shared architecture with the familial and early-onset forms. Alzheimer&#x2019;s Dement J Alzheimer&#x2019;s Assoc. 2018;14:205&#x2013;14. doi: 10.1016/j.jalz.2017.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2017.08.013</ArticleId><ArticleId IdType="pmc">PMC5803427</ArticleId><ArticleId IdType="pubmed">28943286</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinz F, Kapeller A, Pichler M, Klec C. The implications of the long non-coding RNA NEAT1 in non-cancerous Diseases. Int J Mol Sci 2019, 20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6387324</ArticleId><ArticleId IdType="pubmed">30717168</ArticleId></ArticleIdList></Reference><Reference><Citation>An H, Skelt L, Notaro A, Highley JR, Fox AH, La Bella V, Buchman VL, Shelkovnikova TA. ALS-linked FUS mutations confer loss and gain of function in the nucleus by promoting excessive formation of dysfunctional paraspeckles. Acta Neuropathol Commun. 2019;7:7. doi: 10.1186/s40478-019-0658-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0658-x</ArticleId><ArticleId IdType="pmc">PMC6330737</ArticleId><ArticleId IdType="pubmed">30642400</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimoto Y, Nakagawa S, Hirose T, Okano HJ, Takao M, Shibata S, Suyama S, Kuwako K, Imai T, Murayama S, et al. The long non-coding RNA nuclear-enriched abundant transcript 1_2 induces paraspeckle formation in the motor neuron during the early phase of Amyotrophic Lateral Sclerosis. Mol Brain. 2013;6:31. doi: 10.1186/1756-6606-6-31.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1756-6606-6-31</ArticleId><ArticleId IdType="pmc">PMC3729541</ArticleId><ArticleId IdType="pubmed">23835137</ArticleId></ArticleIdList></Reference><Reference><Citation>Shelkovnikova TA, Kukharsky MS, An H, Dimasi P, Alexeeva S, Shabir O, Heath PR, Buchman VL. Protective paraspeckle hyper-assembly downstream of TDP-43 loss of function in Amyotrophic Lateral Sclerosis. Mol Neurodegener. 2018;13:30. doi: 10.1186/s13024-018-0263-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-018-0263-7</ArticleId><ArticleId IdType="pmc">PMC5984788</ArticleId><ArticleId IdType="pubmed">29859124</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Duan Y, Duan G, Wang Q, Zhang K, Deng X, Qian B, Gu J, Ma Z, Zhang S, et al. Stress induces dynamic, cytotoxicity-antagonizing TDP-43 Nuclear bodies via Paraspeckle LncRNA NEAT1-Mediated liquid-liquid phase separation. Mol Cell. 2020;79:443&#x2013;458e447. doi: 10.1016/j.molcel.2020.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.06.019</ArticleId><ArticleId IdType="pubmed">32649883</ArticleId></ArticleIdList></Reference><Reference><Citation>Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, K&#xf6;nig J, Hortob&#xe1;gyi T, Nishimura AL, Zupunski V, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci. 2011;14:452&#x2013;8. doi: 10.1038/nn.2778.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.2778</ArticleId><ArticleId IdType="pmc">PMC3108889</ArticleId><ArticleId IdType="pubmed">21358640</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki H, Shibagaki Y, Hattori S, Matsuoka M. C9-ALS/FTD-linked proline-arginine dipeptide repeat protein associates with paraspeckle components and increases paraspeckle formation. Cell Death Dis. 2019;10:746. doi: 10.1038/s41419-019-1983-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1983-5</ArticleId><ArticleId IdType="pmc">PMC6776546</ArticleId><ArticleId IdType="pubmed">31582731</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacoangeli A, Lin T, Al Khleifat A, Jones AR, Opie-Martin S, Coleman JRI, Shatunov A, Sproviero W, Williams KL, Garton F, et al. Genome-wide Meta-analysis finds the ACSL5-ZDHHC6 locus is Associated with ALS and Links Weight loss to the Disease Genetics. Cell Rep. 2020;33:108323. doi: 10.1016/j.celrep.2020.108323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108323</ArticleId><ArticleId IdType="pmc">PMC7610013</ArticleId><ArticleId IdType="pubmed">33113361</ArticleId></ArticleIdList></Reference><Reference><Citation>van Rheenen W, van der Spek RAA, Bakker MK, van Vugt J, Hop PJ, Zwamborn RAJ, de Klein N, Westra HJ, Bakker OB, Deelen P, et al. Common and rare variant association analyses in Amyotrophic Lateral Sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology. Nat Genet. 2021;53:1636&#x2013;48. doi: 10.1038/s41588-021-00973-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00973-1</ArticleId><ArticleId IdType="pmc">PMC8648564</ArticleId><ArticleId IdType="pubmed">34873335</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglemose R, Hedegaard A, Lehnhoff J, Dimintiyanova KP, Moldovan M, Gr&#xf8;ndahl L, Meehan CF. Potassium channel abnormalities are consistent with early axon degeneration of motor axons in the G127X SOD1 mouse model of Amyotrophic Lateral Sclerosis. Exp Neurol. 2017;292:154&#x2013;67. doi: 10.1016/j.expneurol.2017.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2017.03.008</ArticleId><ArticleId IdType="pubmed">28322742</ArticleId></ArticleIdList></Reference><Reference><Citation>Bostock H, Sharief MK, Reid G, Murray NM. Axonal ion channel dysfunction in Amyotrophic Lateral Sclerosis. Brain. 1995;118(Pt 1):217&#x2013;25. doi: 10.1093/brain/118.1.217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/118.1.217</ArticleId><ArticleId IdType="pubmed">7534598</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, Wiskow O, Han SS, Sandoe J, Perez NP, Williams LA, Lee S, Boulting G, et al. Intrinsic membrane hyperexcitability of Amyotrophic Lateral Sclerosis patient-derived motor neurons. Cell Rep. 2014;7:1&#x2013;11. doi: 10.1016/j.celrep.2014.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Riessland M, Kolisnyk B, Kim TW, Cheng J, Ni J, Pearson JA, Park EJ, Dam K, Acehan D, Ramos-Espiritu LS, et al. Loss of SATB1 induces p21-Dependent Cellular Senescence in post-mitotic dopaminergic neurons. Cell Stem Cell. 2019;25:514&#x2013;530e518. doi: 10.1016/j.stem.2019.08.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2019.08.013</ArticleId><ArticleId IdType="pmc">PMC7493192</ArticleId><ArticleId IdType="pubmed">31543366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang D, Nalls MA, Hallgrimsdottir IB, Hunkapiller J, van der Brug M, Cai F, Kerchner GA, Ayalon G, Bingol B, Sheng M, et al. A meta-analysis of genome-wide association studies identifies 17 new Parkinson&#x2019;s Disease risk loci. Nat Genet. 2017;49:1511&#x2013;6. doi: 10.1038/ng.3955.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3955</ArticleId><ArticleId IdType="pmc">PMC5812477</ArticleId><ArticleId IdType="pubmed">28892059</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson&#x2019;s Disease: a meta-analysis of genome-wide association studies. Lancet Neurol. 2019;18:1091&#x2013;102. doi: 10.1016/S1474-4422(19)30320-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30320-5</ArticleId><ArticleId IdType="pmc">PMC8422160</ArticleId><ArticleId IdType="pubmed">31701892</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng P, Zhou X. Causal effects of blood lipids on Amyotrophic Lateral Sclerosis: a mendelian randomization study. Hum Mol Genet. 2019;28:688&#x2013;97. doi: 10.1093/hmg/ddy384.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddy384</ArticleId><ArticleId IdType="pmc">PMC6360326</ArticleId><ArticleId IdType="pubmed">30445611</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D, Hammar N, Malmstr&#xf6;m H, Ingre C, Jungner I, Ye W, Fang F, Walldius G. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of Amyotrophic Lateral Sclerosis: a more than 20-year follow-up of the Swedish AMORIS cohort. Ann Neurol. 2017;81:718&#x2013;28. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Murdock BJ, Zhou T, Kashlan SR, Little RJ, Goutman SA, Feldman EL. Correlation of Peripheral Immunity with Rapid Amyotrophic Lateral Sclerosis progression. JAMA Neurol. 2017;74:1446&#x2013;54. doi: 10.1001/jamaneurol.2017.2255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.2255</ArticleId><ArticleId IdType="pmc">PMC5822195</ArticleId><ArticleId IdType="pubmed">28973548</ArticleId></ArticleIdList></Reference><Reference><Citation>Zondler L, M&#xfc;ller K, Khalaji S, Bliederh&#xe4;user C, Ruf WP, Grozdanov V, Thiemann M, Fundel-Clemes K, Freischmidt A, Holzmann K, et al. Peripheral monocytes are functionally altered and invade the CNS in ALS patients. Acta Neuropathol. 2016;132:391&#x2013;411. doi: 10.1007/s00401-016-1548-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1548-y</ArticleId><ArticleId IdType="pubmed">26910103</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu GT, Hwang CS, Hsieh CH, Lu CH, Chang SL, Lee JC, Huang CF, Chang HT. Eosinophil-derived neurotoxin is elevated in patients with amyotrophic lateral sclerosis. Mediators of inflammation 2013, 2013:421389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3590756</ArticleId><ArticleId IdType="pubmed">23533305</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>